Welcome to Medications.com

InteKrin Therapeutics Announces Initiation of Phase 2b Study in ... - FOXBusiness

This placebo controlled, double-blind, Phase 2b study includes multiple doses of orally administered INT131 once daily, and Actos(R) (pioglitazone) as an ...

http://www.foxbusiness.com/articl... | Posted: Tue Feb 26 06:02:34 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea